|Articles|August 19, 2016
WAVE Life Sciences Recruits Former Shire Exec as CFO
August 19, 2016
Advertisement
Genetic medicines company WAVE Life Sciences Ltd. (Cambridge, MA) announced that it has appointed Keith Regnante as the company’s Chief Financial Officer.
Mr. Regnante was formerly VP of Finance at Shire where he oversaw finance for R&D. Earlier in his career he was a consultant with Boston Consulting Group.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Grants National Priority Voucher to Tecvayli Combination in Relapsed or Refractory Multiple Myeloma
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
FDA Approves Enhertu Plus Perjeta as First-Line Therapy for HER2-Positive Metastatic Breast Cancer
4
FDA Approves Lerochol for Adults with Elevated LDL Cholesterol
5
